Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins

NeuroToxicology

Volumn 32, Issue 5, 2011, Pages 563-566

  She, Hua ^a   Mao, Zixu ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Myocyte enhancer factor 2; Neurodegenerative diseases; Neurotoxins

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 NITROPROPIONIC ACID; AMYLOID BETA PROTEIN; BETA SECRETASE 1; COCAINE; CYCLIN DEPENDENT KINASE 5; GLUCOSE TRANSPORTER 4; MYOCYTE ENHANCER FACTOR 2; NEUROTOXIN; OXIDOPAMINE;

ALZHEIMER DISEASE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC SPINE; DOPAMINERGIC NERVE CELL; EXCITOTOXICITY; HUMAN; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SUBSTANTIA NIGRA PARS COMPACTA; SYNAPTOGENESIS;

ANIMALS; CELL DEATH; DISEASE MODELS, ANIMAL; HUMANS; MICE; MYOGENIC REGULATORY FACTORS; NEUROTOXINS; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 82455187888     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2011.05.019     Document Type: Article

References (35)

1. Andres V., Cervera M., Mahdavi V. Determination of the consensus binding site for MEF2 expressed in muscle and brain reveals tissue-specific sequence constraints. J Biol Chem 1995, 270:23246-23249.
2. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001, 65:135-172.
3. Brouillet E., Conde F., Beal M.F., Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Prog Neurobiol 1999, 59:427-468.
4. Burton T.R., Dibrov A., Kashour T., Amara F.M. Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway. Brain Res Mol Brain Res 2002, 108:102-120.
5. Chen L., Wang F., Sun X., Zhou J., Gao L., Jiao Y., et al. Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium. Exp Mol Med 2010, 42:205-215.
6. Crespo-Biel N., Camins A., Pallas M., Canudas A.M. Evidence of calpain/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro. Neuropharmacology 2009, 56:422-428.
7. Crespo-Biel N., Camins A., Pelegri C., Vilaplana J., Pallas M., Canudas A.M. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum. Neurosci Lett 2007, 421:77-81.
8. Crocker S.J., Smith P.D., Jackson-Lewis V., Lamba W.R., Hayley S.P., Grimm E., et al. Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci 2003, 23:4081-4091.
9. Dehay B., Bove J., Rodriguez-Muela N., Perier C., Recasens A., Boya P., et al. Pathogenic lysosomal depletion in Parkinson's disease. J Neurosci 2010, 30:12535-12544.
10. Dong J., Canfield J.M., Mehta A.K., Shokes J.E., Tian B., Childers W.S., et al. Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity. Proc Natl Acad Sci U S A 2007, 104:13313-13318.
11. Flavell S.W., Kim T.K., Gray J.M., Harmin D.A., Hemberg M., Hong E.J., et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 2008, 60:1022-1038.
12. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., et al. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 2003, 38:33-46.
13. Gonzalez P., Alvarez V., Menendez M., Lahoz C.H., Martinez C., Corao A.I., et al. Myocyte enhancing factor-2A in Alzheimer's disease: genetic analysis and association with MEF2A-polymorphisms. Neurosci Lett 2007, 411:47-51.
14. Heidenreich K.A., Linseman D.A. Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Mol Neurobiol 2004, 29:155-166.
15. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., Megeney L.A. MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol 1999, 9:1203-1206.
16. Lahiri D.K., Ge Y.W., Rogers J.T., Sambamurti K., Greig N.H., Maloney B. Taking down the unindicated co-conspirators of amyloid beta-peptide-mediated neuronal death: shared gene regulation of BACE1 and APP genes interacting with CREB, Fe65 and YY1 transcription factors. Curr Alzheimer Res 2006, 3:475-483.
17. Li H., Radford J.C., Ragusa M.J., Shea K.L., McKercher S.R., Zaremba J.D., et al. Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo. Proc Natl Acad Sci U S A 2008, 105:9397-9402.
18. Li M., Linseman D.A., Allen M.P., Meintzer M.K., Wang X., Laessig T., et al. Myocyte enhancer factor 2A and 2D undergo phosphorylation and caspase-mediated degradation during apoptosis of rat cerebellar granule neurons. J Neurosci 2001, 21:6544-6552.
19. Mao Z., Bonni A., Xia F., Nadal-Vicens M., Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999, 286:785-790.
20. Mao Z., Wiedmann M. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J Biol Chem 1999, 274:31102-31107.
21. McKinsey T.A., Zhang C.L., Olson E.N. MEF2: a calcium-dependent regulator of cell division, differentiation and death. Trends Biochem Sci 2002, 27:40-47.
22. Molkentin J.D., Olson E.N. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci U S A 1996, 93:9366-9373.
23. Naya F.J., Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 1999, 11:683-688.
24. Okamoto S., Li Z., Ju C., Scholzke M.N., Mathews E., Cui J., et al. Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A 2002, 99:3974-3979.
25. Pfeiffer B.E., Zang T., Wilkerson J.R., Taniguchi M., Maksimova M.A., Smith L.N., et al. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 2010, 66:191-197.
26. Potthoff M.J., Olson E.N. MEF2: a central regulator of diverse developmental programs. Development 2007, 134:4131-4140.
27. Pulipparacharuvil S., Renthal W., Hale C.F., Taniguchi M., Xiao G., Kumar A., et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 2008, 59:621-633.
28. Roberts R.A., Laskin D.L., Smith C.V., Robertson F.M., Allen E.M., Doorn J.A., et al. Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 2009, 112:4-16.
29. Shore P., Sharrocks A.D. The MADS-box family of transcription factors. Eur J Biochem 1995, 229:1-13.
30. Smith P.D., Mount M.P., Shree R., Callaghan S., Slack R.S., Anisman H., et al. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J Neurosci 2006, 26:440-447.
31. Tang X., Wang X., Gong X., Tong M., Park D., Xia Z., et al. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J Neurosci 2005, 25:4823-4834.
32. Tian X., Kai L., Hockberger P.E., Wokosin D.L., Surmeier D.J. MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons. Mol Cell Neurosci 2010, 44:94-108.
33. Yang Q., She H., Gearing M., Colla E., Lee M., Shacka J.J., et al. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy. Science 2009, 323:124-127.
34. Youn H.D., Chatila T.A., Liu J.O. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis. EMBO J 2000, 19:4323-4331.
35. 2+-induced release of the transcription factor MEF2. Science 1999, 286:790-793.